Digitalizing the TIM‑1 Model using Computational Approaches–Part One: TIM‑1 Data Explorer
The TIM-1 gastrointestinal model is one of the most advanced in vitro systems currently available for biorelevant dissolution testing. This technology, the initial version of which was developed nearly 30 years ago and has been subject to a number of significant updates over this period, simulates t...
Saved in:
| Published in | Molecular pharmaceutics Vol. 20; no. 11; pp. 5416 - 5428 |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | English |
| Published |
American Chemical Society
06.11.2023
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 1543-8384 1543-8392 1543-8392 |
| DOI | 10.1021/acs.molpharmaceut.3c00422 |
Cover
| Abstract | The TIM-1 gastrointestinal model is one of the most advanced in vitro systems currently available for biorelevant dissolution testing. This technology, the initial version of which was developed nearly 30 years ago and has been subject to a number of significant updates over this period, simulates the dynamic environment of the human gastrointestinal tract, including pH, transfer times, secretion of bile, enzymes, and electrolytes. In the pharmaceutical industry, the TIM-1 system is used to support drug product design and provide a biopredictive assessment of drug product performance. Typically, the bioaccessibility data sets generated by TIM-1 experiments are used to qualitatively compare formulation performance, and the use of bioaccessibility data as inputs for physiologically based pharmacokinetic (PBPK) modeling for quantitative predictions is limited. To expand the utility of the TIM-1 model beyond standard bioaccessibility measurements (which define the fraction available for absorption), we have developed a computational tool, TIM-1 Data Explorer, to describe the fluid and mass balance within the TIM-1 system. The use of this tool allows a detailed inspection and in-depth interpretation of the experimental data. In addition to mass balance calculation, this model also can be used to describe the critical processes a drug substance would undergo during a TIM-1 experiment, such as dissolution, precipitation on transfer from the stomach to duodenum, and redissolution. The TIM-1 Data Explorer was validated in two case studies. In the first case study with paracetamol, we have shown the ability of the simulator to adequately describe mass transfer events within the TIM-1 system, and in the second study with a weakly basic in-house compound, PF-07059013, the TIM-1 Data Explorer was successfully used to describe dissolution and precipitation processes. |
|---|---|
| AbstractList | The TIM-1 gastrointestinal model is one of the most advanced in vitro systems currently available for biorelevant dissolution testing. This technology, the initial version of which was developed nearly 30 years ago and has been subject to a number of significant updates over this period, simulates the dynamic environment of the human gastrointestinal tract, including pH, transfer times, secretion of bile, enzymes, and electrolytes. In the pharmaceutical industry, the TIM-1 system is used to support drug product design and provide a biopredictive assessment of drug product performance. Typically, the bioaccessibility data sets generated by TIM-1 experiments are used to qualitatively compare formulation performance, and the use of bioaccessibility data as inputs for physiologically based pharmacokinetic (PBPK) modeling for quantitative predictions is limited. To expand the utility of the TIM-1 model beyond standard bioaccessibility measurements (which define the fraction available for absorption), we have developed a computational tool, TIM-1 Data Explorer, to describe the fluid and mass balance within the TIM-1 system. The use of this tool allows a detailed inspection and in-depth interpretation of the experimental data. In addition to mass balance calculation, this model also can be used to describe the critical processes a drug substance would undergo during a TIM-1 experiment, such as dissolution, precipitation on transfer from the stomach to duodenum, and redissolution. The TIM-1 Data Explorer was validated in two case studies. In the first case study with paracetamol, we have shown the ability of the simulator to adequately describe mass transfer events within the TIM-1 system, and in the second study with a weakly basic in-house compound, PF-07059013, the TIM-1 Data Explorer was successfully used to describe dissolution and precipitation processes.The TIM-1 gastrointestinal model is one of the most advanced in vitro systems currently available for biorelevant dissolution testing. This technology, the initial version of which was developed nearly 30 years ago and has been subject to a number of significant updates over this period, simulates the dynamic environment of the human gastrointestinal tract, including pH, transfer times, secretion of bile, enzymes, and electrolytes. In the pharmaceutical industry, the TIM-1 system is used to support drug product design and provide a biopredictive assessment of drug product performance. Typically, the bioaccessibility data sets generated by TIM-1 experiments are used to qualitatively compare formulation performance, and the use of bioaccessibility data as inputs for physiologically based pharmacokinetic (PBPK) modeling for quantitative predictions is limited. To expand the utility of the TIM-1 model beyond standard bioaccessibility measurements (which define the fraction available for absorption), we have developed a computational tool, TIM-1 Data Explorer, to describe the fluid and mass balance within the TIM-1 system. The use of this tool allows a detailed inspection and in-depth interpretation of the experimental data. In addition to mass balance calculation, this model also can be used to describe the critical processes a drug substance would undergo during a TIM-1 experiment, such as dissolution, precipitation on transfer from the stomach to duodenum, and redissolution. The TIM-1 Data Explorer was validated in two case studies. In the first case study with paracetamol, we have shown the ability of the simulator to adequately describe mass transfer events within the TIM-1 system, and in the second study with a weakly basic in-house compound, PF-07059013, the TIM-1 Data Explorer was successfully used to describe dissolution and precipitation processes. The TIM-1 gastrointestinal model is one of the most advanced in vitro systems currently available for biorelevant dissolution testing. This technology, the initial version of which was developed nearly 30 years ago and has been subject to a number of significant updates over this period, simulates the dynamic environment of the human gastrointestinal tract, including pH, transfer times, secretion of bile, enzymes, and electrolytes. In the pharmaceutical industry, the TIM-1 system is used to support drug product design and provide a biopredictive assessment of drug product performance. Typically, the bioaccessibility data sets generated by TIM-1 experiments are used to qualitatively compare formulation performance, and the use of bioaccessibility data as inputs for physiologically based pharmacokinetic (PBPK) modeling for quantitative predictions is limited. To expand the utility of the TIM-1 model beyond standard bioaccessibility measurements (which define the fraction available for absorption), we have developed a computational tool, TIM-1 Data Explorer, to describe the fluid and mass balance within the TIM-1 system. The use of this tool allows a detailed inspection and in-depth interpretation of the experimental data. In addition to mass balance calculation, this model also can be used to describe the critical processes a drug substance would undergo during a TIM-1 experiment, such as dissolution, precipitation on transfer from the stomach to duodenum, and redissolution. The TIM-1 Data Explorer was validated in two case studies. In the first case study with paracetamol, we have shown the ability of the simulator to adequately describe mass transfer events within the TIM-1 system, and in the second study with a weakly basic in-house compound, PF-07059013, the TIM-1 Data Explorer was successfully used to describe dissolution and precipitation processes. |
| Author | Hens, Bart McAllister, Mark Sarcevica, Inese Tomaszewska, Irena |
| AuthorAffiliation | Drug Product Design |
| AuthorAffiliation_xml | – name: Drug Product Design |
| Author_xml | – sequence: 1 givenname: Inese surname: Sarcevica fullname: Sarcevica, Inese email: Inese.Sarcevica@pfizer.com – sequence: 2 givenname: Bart orcidid: 0000-0002-4229-9843 surname: Hens fullname: Hens, Bart – sequence: 3 givenname: Irena surname: Tomaszewska fullname: Tomaszewska, Irena – sequence: 4 givenname: Mark surname: McAllister fullname: McAllister, Mark email: Mark.McAllister@pfizer.com |
| BookMark | eNqNkE1OwzAQRi1UJNrCHcKOTYp_ktZhg6q2QKWisoC1NXUcauTEwXYkYMUVEDfkJKRKhQQrVh5Z3_s08waoV9lKIXRK8IhgSs5B-lFpTb0FV4JUTRgxiXFC6QHqkzRhMWcZ7f3MPDlCA--fMKZJSlkfibl-1AGMftPVYxS2Krpf3n69f5Do1ubKRI3f_c9sWTcBgrYVmGha186C3Cr_9f55By5E60pd_IBzCBAtXmpjnXLH6LAA49XJ_h2ih6vF_ewmXq2vl7PpKgaW4BBT4HzDJc1zorJiQooNFKmU-YZs5JhSxlkCOckAxiTNC8qLMQECLAWGeTGhEzZEZ11vu9pzo3wQpfZSGQOVso0XlHPKKMvYLnrZRaWz3jtVCKm724IDbQTBYqdWtGrFL7Vir7ZtyP401E6X4F7_xaYdu4s82ca1Rv0_uG8PI555 |
| CitedBy_id | crossref_primary_10_33380_2305_2066_2024_13_3_1900 crossref_primary_10_1016_j_xphs_2024_07_006 crossref_primary_10_1007_s40520_024_02860_1 crossref_primary_10_1021_acs_molpharmaceut_4c00878 crossref_primary_10_1016_j_xphs_2024_08_013 |
| Cites_doi | 10.1208/s12249-022-02343-4 10.1016/j.ejps.2022.106165 10.1016/j.ejpb.2018.12.010 10.1016/j.addr.2021.02.001 10.1016/j.ejpb.2022.06.006 10.1016/j.xphs.2021.04.007 10.1021/acs.jmedchem.0c01518 10.1021/mp1001203 10.1021/acs.molpharmaceut.0c00807 10.1016/j.ijpharm.2018.06.050 10.1016/j.ijpharm.2015.11.048 10.1016/j.ejps.2013.08.024 10.1016/j.xphs.2022.01.024 10.1002/jps.24177 10.1016/j.addr.2016.03.009 10.1021/acs.molpharmaceut.9b00799 10.1016/B978-0-12-816813-4.00007-6 10.1016/j.ejps.2016.09.027 10.1016/S1474-6670(17)40931-1 10.1021/acs.molpharmaceut.7b01143 10.1016/j.ejpb.2020.05.008 10.1002/jps.22236 10.1002/ajh.26204 10.1016/S0016-5085(82)80145-5 |
| ContentType | Journal Article |
| Copyright | 2023 American Chemical Society |
| Copyright_xml | – notice: 2023 American Chemical Society |
| DBID | AAYXX CITATION 7X8 |
| DOI | 10.1021/acs.molpharmaceut.3c00422 |
| DatabaseName | CrossRef MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1543-8392 |
| EndPage | 5428 |
| ExternalDocumentID | 10_1021_acs_molpharmaceut_3c00422 b314101809 |
| GroupedDBID | --- -~X 123 4.4 53G 55A 5VS 7~N AABXI ABFRP ABMVS ABQRX ABUCX ACGFS ACS ADHLV AEESW AENEX AFEFF AHGAQ ALMA_UNASSIGNED_HOLDINGS AQSVZ CS3 DU5 EBS ED~ F5P GGK GNL H~9 IH9 JG~ P2P RNS ROL UI2 VF5 VG9 W1F AAYXX ABBLG ABJNI ABLBI BAANH CITATION CUPRZ 7X8 |
| ID | FETCH-LOGICAL-a340t-2a88b8c2dd1e9f71fbaf5ccdb1bc6223834ad19aa615df28f61a1a35a308f7273 |
| IEDL.DBID | ACS |
| ISSN | 1543-8384 1543-8392 |
| IngestDate | Thu Jul 10 23:10:14 EDT 2025 Tue Jul 01 02:22:42 EDT 2025 Thu Apr 24 23:07:42 EDT 2025 Tue Nov 07 03:10:42 EST 2023 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 11 |
| Keywords | digital model in vitro dissolution in silico modeling PBPK modeling oral biopharmaceutics |
| Language | English |
| License | https://doi.org/10.15223/policy-029 https://doi.org/10.15223/policy-037 https://doi.org/10.15223/policy-045 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-a340t-2a88b8c2dd1e9f71fbaf5ccdb1bc6223834ad19aa615df28f61a1a35a308f7273 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-4229-9843 |
| PQID | 2882323937 |
| PQPubID | 23479 |
| PageCount | 13 |
| ParticipantIDs | proquest_miscellaneous_2882323937 crossref_citationtrail_10_1021_acs_molpharmaceut_3c00422 crossref_primary_10_1021_acs_molpharmaceut_3c00422 acs_journals_10_1021_acs_molpharmaceut_3c00422 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2023-11-06 |
| PublicationDateYYYYMMDD | 2023-11-06 |
| PublicationDate_xml | – month: 11 year: 2023 text: 2023-11-06 day: 06 |
| PublicationDecade | 2020 |
| PublicationTitle | Molecular pharmaceutics |
| PublicationTitleAlternate | Mol. Pharmaceutics |
| PublicationYear | 2023 |
| Publisher | American Chemical Society |
| Publisher_xml | – name: American Chemical Society |
| References | ref9/cit9 ref6/cit6 ref3/cit3 ref27/cit27 ref18/cit18 Mittal B. (ref1/cit1) 2020 ref11/cit11 ref25/cit25 ref23/cit23 ref8/cit8 ref5/cit5 ref2/cit2 ref17/cit17 ref10/cit10 ref26/cit26 Minekus M. (ref20/cit20) 2015 Van de Wiele T. (ref14/cit14) 2015 ref19/cit19 ref21/cit21 ref12/cit12 ref15/cit15 Minekus M. (ref16/cit16) 1998 ref22/cit22 ref13/cit13 ref4/cit4 ref24/cit24 ref7/cit7 |
| References_xml | – ident: ref22/cit22 doi: 10.1208/s12249-022-02343-4 – ident: ref23/cit23 doi: 10.1016/j.ejps.2022.106165 – ident: ref9/cit9 doi: 10.1016/j.ejpb.2018.12.010 – ident: ref3/cit3 doi: 10.1016/j.addr.2021.02.001 – start-page: 305 volume-title: The Impact of Food Bioactives on Health: in vitro and ex vivo models year: 2015 ident: ref14/cit14 – ident: ref2/cit2 doi: 10.1016/j.ejpb.2022.06.006 – ident: ref6/cit6 doi: 10.1016/j.xphs.2021.04.007 – ident: ref26/cit26 doi: 10.1021/acs.jmedchem.0c01518 – ident: ref10/cit10 doi: 10.1021/mp1001203 – ident: ref25/cit25 doi: 10.1021/acs.molpharmaceut.0c00807 – volume-title: Development and Validation of a Dynamic Model of the Gastrointestinal Tract year: 1998 ident: ref16/cit16 – ident: ref8/cit8 doi: 10.1016/j.ijpharm.2018.06.050 – ident: ref18/cit18 doi: 10.1016/j.ijpharm.2015.11.048 – ident: ref17/cit17 doi: 10.1016/j.ejps.2013.08.024 – ident: ref21/cit21 doi: 10.1016/j.xphs.2022.01.024 – ident: ref15/cit15 doi: 10.1002/jps.24177 – ident: ref7/cit7 doi: 10.1016/j.addr.2016.03.009 – ident: ref12/cit12 doi: 10.1021/acs.molpharmaceut.9b00799 – start-page: 165 volume-title: How to Integrate Quality by Efficient Design (QbED) in Product Development year: 2020 ident: ref1/cit1 doi: 10.1016/B978-0-12-816813-4.00007-6 – start-page: 37 volume-title: The Impact of Food Bioactives on Health: in vitro and ex vivo models year: 2015 ident: ref20/cit20 – ident: ref5/cit5 doi: 10.1016/j.ejps.2016.09.027 – ident: ref19/cit19 doi: 10.1016/S1474-6670(17)40931-1 – ident: ref13/cit13 doi: 10.1021/acs.molpharmaceut.7b01143 – ident: ref4/cit4 doi: 10.1016/j.ejpb.2020.05.008 – ident: ref11/cit11 doi: 10.1002/jps.22236 – ident: ref27/cit27 doi: 10.1002/ajh.26204 – ident: ref24/cit24 doi: 10.1016/S0016-5085(82)80145-5 |
| SSID | ssj0024523 |
| Score | 2.42368 |
| Snippet | The TIM-1 gastrointestinal model is one of the most advanced in vitro systems currently available for biorelevant dissolution testing. This technology, the... |
| SourceID | proquest crossref acs |
| SourceType | Aggregation Database Enrichment Source Index Database Publisher |
| StartPage | 5416 |
| Title | Digitalizing the TIM‑1 Model using Computational Approaches–Part One: TIM‑1 Data Explorer |
| URI | http://dx.doi.org/10.1021/acs.molpharmaceut.3c00422 https://www.proquest.com/docview/2882323937 |
| Volume | 20 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVABC databaseName: ACS Journals: American Chemical Society Web Editions customDbUrl: eissn: 1543-8392 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0024523 issn: 1543-8384 databaseCode: ACS dateStart: 20040101 isFulltext: true titleUrlDefault: https://pubs.acs.org/action/showPublications?display=journals providerName: American Chemical Society |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LS8QwEA66gnjxLb7JgniyddO0aept8YEKqwtW8FaSNBVRu2K7B_e0f0H8h_tLnLRdy-pBvZZOIMlk5ktm5huE9ghNYJ-lsFTMFFxQSGIJoVqWrzSTkgHgL0IxnSt2fute3nl3dR339wi-Qw6Fyuznnik8rZ54baoK5qppNOMw3zd5fO3jm5pgzyt6ugE0oBan3J1FzV-HMq5JZZOuadIyF-7mbAGF46KdMsvk0e7n0laDnxyO_5nJIpqv4Cdul_qyhKZ0uoz2u-W_bwc4rMuxsgO8j7s1s_XbCopOHu5Nk5GHATg8DNARhxed0fCdYNNS7QmbJPp7XDaKqB4ZcbsiLdfZaPjRBUXF16k--hI8EbnAZSKgfl1Ft2en4fG5VXVosAR1W7nlCM4lV04cEx0kPkmkSDylYkmkYgA8OHVFTAIhADfFicMTRgQR1BO0xRODnNZQI-2leh1hTWEUCuANAATYERZol7lxEHPpgyFUbAOBgmVRdcKyqAieOyQyHycWNaoWdQPx8W5GquI7N203nv4i6nyJvpSkH38Rao5VJoIjauIuItW9fhY5cIuhhmrO3_zvJLbQnOlvXxQ_sm3UyF_7egdQUC53C63_BLr6Cvc |
| linkProvider | American Chemical Society |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NThsxEB5RkGgv0JZWpfTHSIgTm8brXcfpLYKiUAhEIkhIPVi214sQsKnYzQFOvALiDXkSxl6TKL0UuFoey__z2TPzDcAaZTmus1aRybjBBwrNI6VMM2oZy7XmCPi9Kaa3z7tHye_j9Dh4VbpYGOxEiS2V3og_YRegP1zZxdDFn4af3gYznsDqFcylPKHu4dXZPJzw7KU-tRsiBBYJJpJ5WP1vU05DmXJaQ01f0F7rbC_Cn3F_vbPJWWNU6Ya5_ofK8WUDegsLAYySTr173sGMLd7Der-ue7VBBpPgrHKDrJP-hOf6agnk1umJSzlyeo3qjyCQJIOd3v3NLSUuwdo5cS71J6ROGxG-HEknUJjb8v7mro_blhwU9udYcEtVitRugfbyAxxt_xpsdqOQryFSLGlWUayE0MLEWUZtO2_RXKs8NSbTVBuOMESwRGW0rRSiqCyPRc6pooqlijVF7nDUR5gthoX9BMQybIUhlEM4gbcKb9uEJ1k7E7qF16Lhy-DmVIbzVkpvSo-pdIVTkyrDpC6DeFxUaQL7uUvCcf4U0Xgs-remAHmK0OrjzpF4YJ0VRhV2OCpljG8a5ojnWp-fO4jv8Lo76O3JvZ393RV4EyPe8mGR_AvMVpcj-xXxUaW_-YPwAGxFE1k |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LTxsxEB61VEK9tPQl6AOMVHFi03i96zi9IUIEbaGRGiRulp8IlW4QuznAib9Q9R_ySzr2mkTppbRXy2P5NZ7PHs83AO8p87jOWmXGcoMXFOozpUw36xnHteYI-KMr5vCI7x8Xn07Kk_TgFmJhsBM1tlRHJ37Q6gvrE8MA_RDKf0xCDGp67e0wE0msHsKjkqPKB2i0-23OtVfG9G6IElgmmCiWYfOvTQUrZepFK7V4SEfLM3wKctbn-OHke2fa6I65_oPO8f8HtQJPEiglO-0uegYPXPUctkZt3attMp4HadXbZIuM5nzXVy9ADs5OQ-qRs2s0gwQBJRkfHN7e_KQkJFo7J-Fr_Slp00ekp0eyk6jMXX1782uE25d8rdzHmeBANYq03wPd5Us4Hu6Nd_ezlLchU6zoNlmuhNDC5NZS1_c96rXypTFWU204whHBCmVpXylEU9bnwnOqqGKlYl3hA556BUvVpHKrQBzDVhhCOoQVeLrwvit4YftW6B4ej4avQZhXmfSultGlnlMZChcmVaZJXQNxt7DSJBb0kIzj_D6i-Uz0oqUCuY_Q5t3ukai4wRujKjeZ1jLHuw0LBHS91_86iA1YHg2G8svB0ec38DhH2BWjI_lbWGoup-4dwqRGr0dd-A0JYBXc |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Digitalizing+the+TIM%E2%80%911+Model+using+Computational+Approaches%E2%80%93Part+One%3A+TIM%E2%80%911+Data+Explorer&rft.jtitle=Molecular+pharmaceutics&rft.au=Sarcevica%2C+Inese&rft.au=Hens%2C+Bart&rft.au=Tomaszewska%2C+Irena&rft.au=McAllister%2C+Mark&rft.date=2023-11-06&rft.pub=American+Chemical+Society&rft.issn=1543-8384&rft.eissn=1543-8392&rft.volume=20&rft.issue=11&rft.spage=5416&rft.epage=5428&rft_id=info:doi/10.1021%2Facs.molpharmaceut.3c00422&rft.externalDocID=b314101809 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1543-8384&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1543-8384&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1543-8384&client=summon |